VSV-EBOV

VSV-EBOV· Health · 5 sources · Sep 19, 2026Story

DRC Launches Ebola Vaccine Trial Against Bundibugyo Strain

DRC launched Ervebo vaccine trials to test protection against the Bundibugyo Ebola strain, targeting about 20,000 frontline workers in Ituri and North Kivu over six to twelve months with backing from WHO and MSF. The outbreak has 7,541 confirmed cases and 3,639 deaths, with 70,000 doses allocated for the BRAVO/phase 3 study to assess cross-protection against Bundibugyo.

Health· Sep 19, 2026

+1

VSV-EBOV· World · 12 sources · Aug 31, 2026Story

DR Congo Ebola outbreak tops 6,000 cases as containment grows harder

The Democratic Republic of Congo’s Bundibugyo Ebola outbreak has surpassed 6,000 confirmed cases and about 2,911 deaths, marking the deadliest outbreak in the country’s history as it spreads across six provinces amid insecurity and distrust that hinder response efforts. Health workers face elevated safety risks while vaccination campaigns and ongoing vaccine development, including Ervebo use and new candidates, are under way, with WHO stressing the outbreak remains out of control and highlighting the need for global R&D support.

World· Aug 31, 2026

0

VSV-EBOV· Health · 7 sources · Aug 24, 2026Story

DR Congo Ebola Outbreak Expands, Death Toll Rises

The Democratic Republic of the Congo is grappling with the fastest-growing Ebola outbreak in its history, centered in Ituri, with 5,514 confirmed cases and 2,642 deaths and a case fatality rate near 48%, including many deaths occurring outside treatment centers. While tens of thousands of vaccine doses have arrived, authorities warn Ervebo’s effectiveness against the Bundibugyo virus is unproven and call for scaled-up action to reach affected communities and bolster response efforts.

Health· Aug 24, 2026

0

VSV-EBOV· Health · 5 sources · Aug 20, 2026Story

DRC receives 70,000 Ervebo vaccines to bolster frontline Ebola response

The WHO and partners have allocated 70,000 Ervebo Ebola vaccine doses to the Democratic Republic of Congo to bolster the response to the Bundibugyo-driven outbreak, with 50,000 earmarked for frontline health workers and 20,000 for a late-stage trial to determine cross-protection against Bundibugyo. The deployment occurs amid the fastest, deadliest Ebola surge in the country’s history, and while Ervebo is approved for Zaire ebolavirus, its effectiveness against Bundibugyo remains under study.

Health· Aug 20, 2026

0

VSV-EBOV

DRC Launches Ebola Vaccine Trial Against Bundibugyo Strain

DR Congo Ebola outbreak tops 6,000 cases as containment grows harder

DR Congo Ebola Outbreak Expands, Death Toll Rises

DRC receives 70,000 Ervebo vaccines to bolster frontline Ebola response

VSV-EBOV

DRC Launches Ebola Vaccine Trial Against Bundibugyo Strain

DR Congo Ebola outbreak tops 6,000 cases as containment grows harder

DR Congo Ebola Outbreak Expands, Death Toll Rises

DRC receives 70,000 Ervebo vaccines to bolster frontline Ebola response

VSV-EBOV across IJR

VSV-EBOV across IJR

Latest VSV-EBOV news and discussion

DRC Launches Ebola Vaccine Trial Against Bundibugyo Strain

DR Congo Ebola outbreak tops 6,000 cases as containment grows harder

DR Congo Ebola Outbreak Expands, Death Toll Rises

DRC receives 70,000 Ervebo vaccines to bolster frontline Ebola response

Latest VSV-EBOV news and discussion

DRC Launches Ebola Vaccine Trial Against Bundibugyo Strain

DR Congo Ebola outbreak tops 6,000 cases as containment grows harder

DR Congo Ebola Outbreak Expands, Death Toll Rises

DRC receives 70,000 Ervebo vaccines to bolster frontline Ebola response

VSV-EBOV across IJR

VSV-EBOV across IJR